Macralytics CMS

Measure Set / Program: 2026 MIPS Quality Measures

RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer Who Receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy

June 11, 2026
Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer

June 11, 2026
Appropriate Workup Prior to Endometrial Ablation

June 11, 2026
Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)

June 11, 2026
Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)

June 11, 2026
Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician

June 11, 2026
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

June 11, 2026
Proportion of Patients Sustaining a Bladder or Bowel Injury at the time of any Pelvic Organ Prolapse Repair

June 11, 2026
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling

June 11, 2026
Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy

June 11, 2026